UB Paderborn / Katalog / Suche / in CDI

The diagnosis and management of congenital hemophilia

Seminars in thrombosis and hemostasis, 2012-10, Vol.38 (7), p.727

Carcao, Manuel D

2012

Link zum Volltext

Verfügbarkeit prüfen

Individualizing factor replacement therapy in severe hemophilia

Seminars in thrombosis and hemostasis, 2015-11, Vol.41 (8), p.864

2015

Link zum Volltext

Verfügbarkeit prüfen

Rare case of refractory mixed autoimmune hemolytic anemia in a 6-year-old child: a case report

Journal of medical case reports, 2023-10, Vol.17 (1), p.1-418, Article 418

2023

Link zum Volltext

Verfügbarkeit prüfen

Hemophilia in a Changing Treatment Landscape

Hematology/oncology clinics of North America, 2019-06, Vol.33 (3), p.409-423

2019

Link zum Volltext

Verfügbarkeit prüfen

Genetic determinants of VWF clearance and FVIII binding modify FVIII pharmacokinetics in pediatric hemophilia A patients

Blood, 2019-09, Vol.134 (11), p.880-891

2019

Link zum Volltext

Verfügbarkeit prüfen

Genotype–phenotype correlation in children with hereditary spherocytosis

British journal of haematology, 2020-11, Vol.191 (3), p.486-496

2020

Link zum Volltext

Verfügbarkeit prüfen

NBEAL2 mutations and bleeding in patients with gray platelet syndrome

Platelets (Edinburgh), 2018-08, Vol.29 (6), p.632-635

2018

Link zum Volltext

Verfügbarkeit prüfen

Unravelling the effect of blood group on FVIII:C levels and response to DDAVP in 20 males with a single genotype (Twillingate Variant) causing Haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2024-01, Vol.30 (1), p.116-122

2024

Link zum Volltext

Verfügbarkeit prüfen

Recombinant factor XIII: a safe and novel treatment for congenital factor XIII deficiency

Blood, 2012-05, Vol.119 (22), p.5111-5117

2012

Link zum Volltext

Verfügbarkeit prüfen

Comparative pharmacokinetics of two extended half‐life FVIII concentrates (Eloctate and Adynovate) in adolescents with hemophilia A: Is there a difference?

Journal of thrombosis and haemostasis, 2019-07, Vol.17 (7), p.1085-1096

2019

Link zum Volltext

Verfügbarkeit prüfen

Use of minigene assays as a useful tool to confirm the pathogenic role of intronic variations of the ANK1 gene: Report of two cases of hereditary spherocytosis

British journal of haematology, 2023-05, Vol.201 (4), p.e46-e49

2023

Link zum Volltext

Verfügbarkeit prüfen

A Practical, One-Clinic Visit Protocol for Pharmacokinetic Profile Generation with the ADVATE myPKFiT Dosing Tool in Severe Hemophilia A Subjects

Thrombosis and haemostasis, 2021-10, Vol.121 (10), p.1326

2021

Link zum Volltext

Verfügbarkeit prüfen

Long‐term follow‐up of patients with congenital thrombotic thrombocytopenia purpura receiving a plasma‐derived factor VIII (Koate) that contains ADAMTS13

Haemophilia : the official journal of the World Federation of Hemophilia, 2023-11, Vol.29 (6), p.1638-1645

2023

Link zum Volltext

Verfügbarkeit prüfen

Practical considerations in choosing a factor VIII prophylaxis regimen: Role of clinical phenotype and trough levels

Thrombosis and haemostasis, 2016, Vol.115 (5), p.913

2016

Link zum Volltext

Verfügbarkeit prüfen

Abnormal fibrinolysis recognized by thromboelastography in a case of severe bleeding with normal coagulation and platelet function, leads to detection of a novel SERPINF2 variant causing severe alpha‐2‐antiplasmin deficiency

British journal of haematology, 2019-09, Vol.186 (6), p.e198-e201

2019

Link zum Volltext

Verfügbarkeit prüfen

Dieulafoy lesions and PHACE syndrome

Pediatric dermatology, 2019-11, Vol.36 (6), p.902-905

2019

Link zum Volltext

Verfügbarkeit prüfen

Correlation between phenotype and genotype in a large unselected cohort of children with severe hemophilia A

Blood, 2013-05, Vol.121 (19), p.3946-3952

2013

Link zum Volltext

Verfügbarkeit prüfen

Glanzmann thrombasthenia platelets compete with transfused platelets, reducing the haemostatic impact of platelet transfusions

British journal of haematology, 2018-05, Vol.181 (3), p.410-413

2018

Link zum Volltext

Verfügbarkeit prüfen

Idiopathic pulmonary arterial hypertension – a unrecognized cause of high‐shear high‐flow haemostatic defects (otherwise referred to as acquired von Willebrand syndrome) in children

British journal of haematology, 2018-10, Vol.183 (2), p.267-275

2018

Link zum Volltext

Verfügbarkeit prüfen

Vincristine for successful treatment of steroid-dependent infantile hemangiomas

Pediatrics (Evanston), 2015-06, Vol.135 (6), p.e1501

2015

Link zum Volltext

Verfügbarkeit prüfen

Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon

Pediatric blood & cancer, 2012-11, Vol.59 (5), p.934-938

2012

Link zum Volltext

Verfügbarkeit prüfen

The effectiveness and safety of octocog alfa in patients with hemophilia A: up to 7-year follow-up of the real-world AHEAD international study

Therapeutic advances in hematology, 2024-01, Vol.15, p.20406207231218624-20406207231218624

2024

Link zum Volltext

Verfügbarkeit prüfen

Utility of factor VIII and factor VIII to von Willebrand factor ratio in identifying 277 unselected carriers of hemophilia A

American journal of hematology, 2017-06, Vol.92 (6), p.E94-E96

2017

Link zum Volltext

Verfügbarkeit prüfen

The use of rapamycin to treat vascular tumours and malformations: A single-centre experience

Paediatrics & child health, 2021-02, Vol.26 (1), p.e25-e32

2021

Link zum Volltext

Verfügbarkeit prüfen

Bleeding before prophylaxis in severe hemophilia: paradigm shift over two decades

Haematologica (Roma), 2015-03, Vol.100 (3), p.e84-e86

2015

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

The diagnosis and management of congenital hemophilia

Individualizing factor replacement therapy in severe hemophilia

Rare case of refractory mixed autoimmune hemolytic anemia in a 6-year-old child: a case report

Hemophilia in a Changing Treatment Landscape

Genetic determinants of VWF clearance and FVIII binding modify FVIII pharmacokinetics in pediatric hemophilia A patients

Genotype–phenotype correlation in children with hereditary spherocytosis

NBEAL2 mutations and bleeding in patients with gray platelet syndrome

Unravelling the effect of blood group on FVIII:C levels and response to DDAVP in 20 males with a single genotype (Twillingate Variant) causing Haemophilia A

Recombinant factor XIII: a safe and novel treatment for congenital factor XIII deficiency

Comparative pharmacokinetics of two extended half‐life FVIII concentrates (Eloctate and Adynovate) in adolescents with hemophilia A: Is there a difference?

Use of minigene assays as a useful tool to confirm the pathogenic role of intronic variations of the ANK1 gene: Report of two cases of hereditary spherocytosis

A Practical, One-Clinic Visit Protocol for Pharmacokinetic Profile Generation with the ADVATE myPKFiT Dosing Tool in Severe Hemophilia A Subjects

Long‐term follow‐up of patients with congenital thrombotic thrombocytopenia purpura receiving a plasma‐derived factor VIII (Koate) that contains ADAMTS13

Practical considerations in choosing a factor VIII prophylaxis regimen: Role of clinical phenotype and trough levels

Abnormal fibrinolysis recognized by thromboelastography in a case of severe bleeding with normal coagulation and platelet function, leads to detection of a novel SERPINF2 variant causing severe alpha‐2‐antiplasmin deficiency

Dieulafoy lesions and PHACE syndrome

Correlation between phenotype and genotype in a large unselected cohort of children with severe hemophilia A

Glanzmann thrombasthenia platelets compete with transfused platelets, reducing the haemostatic impact of platelet transfusions

Idiopathic pulmonary arterial hypertension – a unrecognized cause of high‐shear high‐flow haemostatic defects (otherwise referred to as acquired von Willebrand syndrome) in children

Vincristine for successful treatment of steroid-dependent infantile hemangiomas

Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon

The effectiveness and safety of octocog alfa in patients with hemophilia A: up to 7-year follow-up of the real-world AHEAD international study

Utility of factor VIII and factor VIII to von Willebrand factor ratio in identifying 277 unselected carriers of hemophilia A

The use of rapamycin to treat vascular tumours and malformations: A single-centre experience

Bleeding before prophylaxis in severe hemophilia: paradigm shift over two decades

Suchergebnisse filtern